These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 4609432

  • 1. The UGDP--tolbutamide and mortality.
    Knowles HC.
    Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
    [No Abstract] [Full Text] [Related]

  • 2. Comments on the UGDP study.
    Schöffling K.
    Horm Metab Res; 1974; Suppl 4():188-91. PubMed ID: 4608018
    [No Abstract] [Full Text] [Related]

  • 3. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.
    Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026
    [No Abstract] [Full Text] [Related]

  • 4. A progress report on the University Group Diabetes Program.
    Prout TE.
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):244-51. PubMed ID: 809369
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phenformin and vascular complications of diabetes.
    Med Lett Drugs Ther; 1972 Jan 07; 14(1):1-2. PubMed ID: 4567560
    [No Abstract] [Full Text] [Related]

  • 7. [The venture of University Group Diabetes Program (UGDP). Some personal reflexions. Tolbutamide and phenformin under accusation].
    Pirart J.
    Nouv Presse Med; 1972 Jan 29; 1(5):325-8. PubMed ID: 5010448
    [No Abstract] [Full Text] [Related]

  • 8. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
    Knatterud GL, Meinert CL, Klimt CR, Osborne RK, Martin DB.
    JAMA; 1971 Aug 09; 217(6):777-84. PubMed ID: 4935344
    [No Abstract] [Full Text] [Related]

  • 9. Editorial: Oral hypoglycemic drugs.
    Scoville AB.
    J Tenn Med Assoc; 1975 Apr 09; 68(4):319-20. PubMed ID: 1117723
    [No Abstract] [Full Text] [Related]

  • 10. The controversial American University Group Diabetes Study--a look at sulfonylurea and biguanide therapy.
    Kilo C, Williamson JR.
    Horm Metab Res Suppl; 1985 Apr 09; 15():102-4. PubMed ID: 3908276
    [No Abstract] [Full Text] [Related]

  • 11. [Considerations on diabetic angiopathies. Relations to hypoglycemic treatments].
    Lubetzki J.
    Nouv Presse Med; 1972 Mar 11; 1(11):715-8. PubMed ID: 5022249
    [No Abstract] [Full Text] [Related]

  • 12. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Polosa P, Mughini L.
    Minerva Med; 1974 Aug 29; 65(59):383-9. PubMed ID: 4213556
    [No Abstract] [Full Text] [Related]

  • 13. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB.
    Journ Annu Diabetol Hotel Dieu; 1984 Aug 29; ():183-91. PubMed ID: 6443219
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A prospective view of the treatment of adult-onset diabetes with special reference to the University Group Diabetes Program and oral hypoglycemic agents.
    Prout TE.
    Med Clin North Am; 1971 Jul 29; 55(4):1065-75. PubMed ID: 4946757
    [No Abstract] [Full Text] [Related]

  • 16. The influence of diagnostic criteria on the mortality findings in the University Group Diabetic Programme study of diabetic therapy.
    Gray RH.
    Med J Aust; 1973 Mar 24; 1(12):594-6. PubMed ID: 4573383
    [No Abstract] [Full Text] [Related]

  • 17. The UGDP controversy. Clinical trials versus clinical impressions.
    Prout TE, Knatterud GL, Meinert CL, Klimt CR.
    Diabetes; 1972 Oct 24; 21(10):1035-40. PubMed ID: 4561330
    [No Abstract] [Full Text] [Related]

  • 18. [Causes of death in diabetes mellitus].
    Akhmetzianov AM, Mazovetskiĭ AG, Kliachko VR.
    Probl Endokrinol (Mosk); 1975 Oct 24; 21(1):103-11. PubMed ID: 1094446
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical testing of Tolbutaphen in the treatment of adult diabetes].
    Schneider J, Kaffarnik H.
    Z Allgemeinmed; 1975 Jan 20; 51(2):74-5. PubMed ID: 766424
    [No Abstract] [Full Text] [Related]

  • 20. The crux of the UGDP. Spurious results and biologically inappropriate data analysis.
    Kilo C, Miller JP, Williamson JR.
    Diabetologia; 1980 Mar 20; 18(3):179-85. PubMed ID: 6989693
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.